Delivery Order SPE2DB22D2103-SPE2DB24FR9QF

Award Date 7/8/24
Potential Completion Date 7/29/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $7,322.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The order is for the supply of 420 mg Imbruvica tablets, a prescription medication, with a completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of IMBRUVICA 280 MG TABLET 28S to the Defense Logistics Agency (DLA). The $36,613.35 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support Department of Defense (DoD) facilities globally....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, involves the delivery of IMBRUVICA 140 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $23,537.16, has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 Firm Fixed Price Delivery Order contract is for the provision of the drug IMBRUVICA 280 MG TABLET 28S. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $7,322.67 and covers the delivery of IMBRUVICA 140 MG TABLET 28S, a specialty pharmaceutical product, with a performance period through April 30, 2024. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $7,322.67 for the provision of IMBRUVICA 280 MG TABLET 28S. The contract is a firm fixed price agreement with the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $7,575.75. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product. The IDC has a ceiling value of $999,999,999 and runs through November 2026, serving as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a delivery order contract with a firm fixed price pricing type, valued at $7,322.67, to provide Imbruvica 420 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $7,322.67 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to military...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office division by the Defense Logistics Agency (DLA) for the supply of IMBRUVICA 140 MG CAPSULE 90S. The order has a firm fixed price of $23,537.16 and a performance period through September 24, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) the DLA Troop Support Medical has awarded to Amerisourcebergen, valued up to $999,999,999 through December 2025, for providing a...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9QF
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $21,968.01, is a delivery order contract for the supply of IMBRUVICA 280 MG TABLET 28S to the Defense Logistics Agency (DLA). The contract does not have a set-aside designation and is a firm-fixed-price contract with a completion date of July 29, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/7/24, 10:42 AM